Treatment | Children with Cancer UK

Filter by Cancer Type

Understanding MLL leukaemia and identifying targets which could increase survival

Exploring the role of a novel tumour suppressor in leukaemia

Dr David Clynes, The MRC Weatherall Institute of Molecular Medicine

Preserving the family medical history of cancer in children collected over 30 years

Preservation and analysis of pathology records and family histories of children with cancer

Dr John Bithell, University of Oxford

Focusing on quality of life after treatment for survivors: research into childhood brain tumours involving the hypothalamus

Markers of hypothalamic dysfunction in children with hypothalamo-pituitary tumours or pituitary maldevelopment

Dr Manuela Cerbone, University College London

Modification of the Asparaginase-based drugs for ALL

Modification of the Asparaginase-based drugs for ALL

Dr Oleg Gerasimenko, Cardiff University

Identifying new leukaemia treatments by targeting cholesterol and fatty acid dependence

Harnessing SMAD7 induced transcriptional pathways for novel anti-leukaemia therapies

Dr Owen Williams, UCL Great Ormond Street Institute of Child Health

New neuroblastoma treatments could increase likelihood of irradiating all cancerous tissue in the body

Two radiopharmaceuticals for treatment of neuroblastoma

Professor Anthony Chalmers, University of Glasgow

1 … 4 5 6 7 8 … 19